A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 153 participants.
Also called NCT02608697
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 153 participants
- Sponsor
- Catabasis Pharmaceuticals
- Registry
-
NCT02608697
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02608697. Randomized; quadruple masking; primary purpose treatment. Start 2015-10 (registry gives no type); primary completion 2016-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Assess the Safety and Efficacy of CAT-2054 in Combination With Atorvastatin in Patients With Hypercholesterolemia
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- CAT-2054
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Atorvastatin
- Lead sponsor
- Catabasis Pharmaceuticals
Record details
- Record id
cardio:ct-nct02608697- Content hash
132e7668326f9449e9b712942e44a63eafc70035c7b126aea64a67250e378a88